HBV REACTIVATION INDUCED BY CHEMOTHERAPY: A CASE REPORT
- At: 2015 FIP Congress in Düsseldorf (Germany)
- Type: Poster
- By: HSIEH, Hui-Hsia (Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Pharmacy, Taichung, China Taiwan)
- Co-author(s): Tien-Yuan Wu
Gemcitabine and carboplatin are the primary chemotherapy for consecutive patients presenting with locally advanced or metastatic transitional cell carcinoma (TCC) of the urothelium. However, chemotherapy may induce hepatitis B virus reactivation in the hepatitis B carriers.
A 51-year-old HBV carrier was diagnosed with stage IV TCC of urothelium... The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.